These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 1991155
1. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant. Seeger W, Thede C, Günther A, Grube C. Biochim Biophys Acta; 1991 Jan 04; 1081(1):45-52. PubMed ID: 1991155 [Abstract] [Full Text] [Related]
8. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs. Wang Z, Chang Y, Schwan AL, Notter RH. Am J Respir Cell Mol Biol; 2007 Oct 04; 37(4):387-94. PubMed ID: 17556674 [Abstract] [Full Text] [Related]
9. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine. Wang Z, Schwan AL, Lairson LL, O'Donnell JS, Byrne GF, Foye A, Holm BA, Notter RH. Am J Physiol Lung Cell Mol Physiol; 2003 Sep 04; 285(3):L550-9. PubMed ID: 12902318 [Abstract] [Full Text] [Related]
10. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Hall SB, Venkitaraman AR, Whitsett JA, Holm BA, Notter RH. Am Rev Respir Dis; 1992 Jan 04; 145(1):24-30. PubMed ID: 1731593 [Abstract] [Full Text] [Related]
11. Primary importance of zwitterionic over anionic phospholipids in the surface-active function of calf lung surfactant extract. Wang Z, Gurel O, Weinbach S, Notter RH. Am J Respir Crit Care Med; 1997 Oct 04; 156(4 Pt 1):1049-57. PubMed ID: 9351602 [Abstract] [Full Text] [Related]
12. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. Venkitaraman AR, Hall SB, Whitsett JA, Notter RH. Chem Phys Lipids; 1990 Dec 04; 56(2-3):185-94. PubMed ID: 2095991 [Abstract] [Full Text] [Related]
13. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles. Beck-Broichsitter M, Ruppert C, Schmehl T, Günther A, Seeger W. Biochim Biophys Acta; 2014 Jan 04; 1838(1 Pt B):474-81. PubMed ID: 24184425 [Abstract] [Full Text] [Related]
17. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures. Yu SH, Possmayer F. Biochim Biophys Acta; 1990 Oct 01; 1046(3):233-41. PubMed ID: 2223863 [Abstract] [Full Text] [Related]
18. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins. Cockshutt AM, Absolom DR, Possmayer F. Biochim Biophys Acta; 1991 Sep 11; 1085(2):248-56. PubMed ID: 1892895 [Abstract] [Full Text] [Related]
19. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant. Wang Z, Hall SB, Notter RH. J Lipid Res; 1996 Apr 11; 37(4):790-8. PubMed ID: 8732779 [Abstract] [Full Text] [Related]
20. Dynamic surface activity of a fully synthetic phospholipase-resistant lipid/peptide lung surfactant. Walther FJ, Waring AJ, Hernandez-Juviel JM, Gordon LM, Schwan AL, Jung CL, Chang Y, Wang Z, Notter RH. PLoS One; 2007 Oct 17; 2(10):e1039. PubMed ID: 17940603 [Abstract] [Full Text] [Related] Page: [Next] [New Search]